Incorrect funding
In the published article, there was an error in the Funding statement [LGH20H190003]. The correct Funding statement appears below.
Statements
Funding
This study has received funding from the following: Zhejiang Provincial Basic Public Welfare Research Project (LGF20H190003), Medical Health Science and Technology General Project of Zhejiang Provincial Health Commission (2020KY351), and Taizhou Science and Technology Planning Project of Zhejiang Province (1901ky02).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
hepatocellular carcinoma, nectin-1, prognostic, cell proliferation, metastasis
Citation
Wang X, Xing Z, Chen H, Yang H, Wang Q and Xing T (2023) Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma. Front. Oncol. 13:1134139. doi: 10.3389/fonc.2023.1134139
Received
30 December 2022
Accepted
20 January 2023
Published
21 March 2023
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2023
Updates
Copyright
© 2023 Wang, Xing, Chen, Yang, Wang and Xing.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tongjing Xing, xingtj518@sina.com; Xuequan Wang, yantaiquan@126.com
†These authors share first authorship
This article was submitted to Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.